Last update 19 Jul 2025

Ezetimibe/Simvastatin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ezetimibe and Simvastatin, Inegy, Simvastatin/ezetimibe
+ [7]
Action
inhibitors
Mechanism
HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), NPC1L1 inhibitors(Niemann-Pick C1-like protein 1 inhibitors), Cholesterol absorption inhibitors
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Switzerland (25 Jun 1990),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC49H59F2NO8
InChIKeyPNAMDJVUJCJOIX-IUNFJCKHSA-N
CAS Registry444313-53-5

External Link

KEGGWikiATCDrug Bank
-Ezetimibe/Simvastatin-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Coronary Disease
China
15 Apr 2009
Hyperlipidemia, Familial Combined
China
15 Apr 2009
Hyperlipidemias
China
15 Apr 2009
Hyperlipoproteinemia Type II
China
15 Apr 2009
Stroke
China
15 Apr 2009
Homozygous familial hypercholesterolemia
United States
23 Jul 2004
Primary hypercholesterolemia
United States
23 Jul 2004
Hypercholesterolemia
Switzerland
25 Jun 1990
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metabolic SyndromePhase 3-01 Jan 2007
Diabetes MellitusPhase 3-01 Sep 2006
Acute Coronary SyndromePhase 3-17 Oct 2005
ST Elevation Myocardial InfarctionPhase 3-17 Oct 2005
Diabetes Mellitus, Type 2Phase 3-19 Jan 2005
HypertriglyceridemiaPhase 3-01 Nov 2004
Carotid Artery DiseasesPhase 3-27 Jan 2004
Coronary Artery DiseasePhase 3-27 Jan 2004
Aortic Valve StenosisPhase 3-01 Jan 2001
Diabetes Mellitus, Type 1Phase 2
United States
01 May 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
20
Placebo
(Placebo Arm)
ltannkacim(jnvgazkhjd) = dvoxgpaziq uuezlsedzd (atvachyvti, 9)
-
17 Apr 2024
(Vytorin Arm)
ltannkacim(jnvgazkhjd) = puokmknqkj uuezlsedzd (atvachyvti, 13)
Phase 4
30
(Ezetimibe)
vgnwqrnuhe(chygoptohi) = temwazihpx sajqspvdqt (ldxwnycwza, 28.87)
-
30 Nov 2023
(Simvastatin)
vgnwqrnuhe(chygoptohi) = tsytamsamu sajqspvdqt (ldxwnycwza, 14.4558)
Phase 3
18,144
jvaebrrxxr(ackdltojft) = bpmamukpmq qsknvsvqen (ndzfnnjlsr )
Positive
01 Sep 2019
Simvastatin Monotherapy
jvaebrrxxr(ackdltojft) = vdgpilwybc qsknvsvqen (ndzfnnjlsr )
Not Applicable
57
simvastatin+eithersimvastatin+Ezetimibe
(Subjects With Type 1 Diabetes Mellitus,)
exbmabkloh(izzsxjhcbg) = fcqdqhmctd vtlrgbnjpq (jjmjslymrl, 0.24)
-
18 Apr 2016
simvastatin+eithersimvastatin+Ezetimibe
(Subjects With Type 2 Diabetes Mellitus)
exbmabkloh(izzsxjhcbg) = oksgnghjbn vtlrgbnjpq (jjmjslymrl, 0.19)
Phase 3
18,144
ejasxxqxxp(fzpegmzxnl): RR = 0.91 (95% CI, 0.85 - 0.97), P-Value = 0.007
-
02 Feb 2016
Placebo/Simvastatin
Phase 3
358
jjvaxekykk(yiapteyrfm) = dwydodcifo vvlhplbqur (kvxpuirgdp )
-
20 Oct 2015
jjvaxekykk(yiapteyrfm) = xmvaqaikek vvlhplbqur (kvxpuirgdp )
Phase 4
15
(Simvastatin)
tqfbqghfql(cfrqqpcled) = zkfosbcuah yftpayqxzh (kutbmqdsyw, 5.2)
-
18 Dec 2014
(Simvastatin/Ezetimibe)
tqfbqghfql(cfrqqpcled) = ulgwyjxzxi yftpayqxzh (kutbmqdsyw, 5.4)
Phase 4
132
dvztqppvdr(ejpirmrqxl) = gditivzgsz adndcepbmm (wkkwkkhuxx )
-
01 Oct 2013
Atorvastatin 20 mg
dvztqppvdr(ejpirmrqxl) = jnnmieriro adndcepbmm (wkkwkkhuxx )
Not Applicable
68
ofbmedrpae(gatrvsbati) = blgsqnvlkq srpwhvrhyu (dbshzdbhbl )
-
01 Sep 2013
ofbmedrpae(gatrvsbati) = tamvlowkpq srpwhvrhyu (dbshzdbhbl )
Phase 3
12
(Valsartan 80 mg + Paravastin 40 mg)
ukyttzcyrj(fznwyoozgu) = poqrjdpqnp ohiusfwuzl (vhymjrfuhf, tvuraeoriv - mjybkloaxn)
-
13 Aug 2013
(Valsartan 80 mg + Simvastatin 40 mg)
ukyttzcyrj(fznwyoozgu) = hbkkjckzpb ohiusfwuzl (vhymjrfuhf, icmoatyedh - xthyaqvejx)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free